Trial
NCT04485026
Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung Carcinoma
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
National Cancer Institute (NCI)
Condition
Non Small Cell Lung Cancer
Intervention
Local consolidative radiation therapy
Why stopped
No enrollments, low patient population as well as a dramatic change in the insurance approval processes for oligoprogressive state with eviCore saying they do not support SBRT in this setting at all.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-17